NCT02691845

Brief Summary

The investigators propose a randomized clinical trial in which 240 depressed individuals are assigned to one of three arms, with each successive arm having an added component that may serve to increase and maintain physical activity:

  1. 1.brief advice (BA) to exercise (control condition);
  2. 2.BA + supervised \& home-based exercise (SHE) + health education (HE) contact control; and
  3. 3.BA + SHE+ cognitive-behavioral sessions focused on increasing and maintaining exercise (CBEX).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
240

participants targeted

Target at P75+ for not_applicable depression

Timeline
Completed

Started Feb 2016

Longer than P75 for not_applicable depression

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2016

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

February 18, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 25, 2016

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
Last Updated

December 28, 2022

Status Verified

December 1, 2022

Enrollment Period

5.1 years

First QC Date

February 18, 2016

Last Update Submit

December 27, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in minutes of moderate-vigorous physical activity (MVPA) per week assessed via accelerometer

    from baseline to 3 months, 6 months, 9 months

Secondary Outcomes (9)

  • change in depression assessed via Quick Inventory of Depression Symptoms

    Baseline to 3 months, 6 months, 9 months

  • change in cardiorespiratory fitness

    Baseline to 3 months, 6 months, 9 months

  • change in self-report of MVPA assessed via International physical activity questionnaire

    Baseline to 3 months, 6 months, 9 months

  • change in Self-report of pain assessed via the SF-36

    Baseline to 3 months, 6 months, 9 months

  • change in Self-report of overall health assessed via the SF-36

    Baseline to 3 months, 6 months,9 months

  • +4 more secondary outcomes

Study Arms (3)

BA

OTHER

Brief advice to exercise. This serves as a control condition.

Behavioral: BA (brief advice)

BA + SHE + HE

ACTIVE COMPARATOR

Brief advice to exercise + supervised \& home-based exercise + health education

Behavioral: BA (brief advice)Behavioral: SHE (supervised and home-based exercise)Behavioral: HE (health education)

BA + SHE + CBEX

EXPERIMENTAL

Brief advice to exercise + supervised \& home-based exercise + cognitive-behavioral sessions focused on increasing and maintaining exercise

Behavioral: BA (brief advice)Behavioral: SHE (supervised and home-based exercise)Behavioral: CBEX (cognitive-behavioral sessions focused on increasing and maintaining exercise)

Interventions

BABA + SHE + CBEXBA + SHE + HE
BA + SHE + CBEXBA + SHE + HE
BA + SHE + HE

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Sedentary, i.e., have not participated regularly in moderate-to-vigorous physical activity (MVPA) for 90 minutes per week or more for more than 6 weeks of the past 12 weeks.
  • Medically cleared for MVPA, documented by a note from their primary care provider.
  • No significant medical condition or physical disability that would interfere with physical activity or study participation. The investigators will exclude individuals with significant cardiovascular disease, hematologic disorders, and autoimmune disorders. The investigators will also exclude individuals who are planning a surgery in the next 9 months and those with dementia.
  • Elevated depression symptoms. To meet criteria for elevated symptoms, participants must have a QIDS score of 8 or greater (i.e., at least moderate depression levels), and must have a score of "1" or greater on at least one of the two core DSM-V depressive symptoms, i.e., sad mood or anhedonia. -
  • No current bulimia or anorexia (past 3 months); no MDD with psychotic symptoms (past 6 months); no history of bipolar disorder, schizophrenia, or a chronic psychotic condition; (assessed using the SCID).
  • No hazardous drug or alcohol use in the past 6 months, as assessed by: a. no substance abuse treatment in the past 6 months; and b. does not meet criteria for a moderate or severe substance use disorder in the past 6 months.
  • Depression is not very severe, i.e., QIDS score is \<= 20.
  • No suicidality requiring immediate treatment.
  • Not pregnant or planning on becoming pregnant in the next year.
  • Understands English sufficiently well to consent and complete study assessments.
  • Aged 18-65.
  • Able to make one of the 2 available exercise class times.
  • Able to walk 1 mile
  • Weight does not exceed 375 lbs.
  • If participants are aged 60 or older, or if there is any concern about their cognitive capacity, participants will undergo a brief cognitive functioning screener, the Montreal Cognitive Assessment (MOCA). Participants are required to achieve a score within 1 SD of the mean for their age and education level to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Butler Hospital

Providence, Rhode Island, 02906, United States

Location

MeSH Terms

Conditions

Depression

Interventions

Crisis InterventionHelium

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

PsychotherapyBehavioral Disciplines and ActivitiesNoble GasesElementsInorganic ChemicalsGases

Study Officials

  • Lisa Uebelacker, PhD

    Butler Hospital

    PRINCIPAL INVESTIGATOR
  • Ana Abrantes, PhD

    Butler Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 18, 2016

First Posted

February 25, 2016

Study Start

February 1, 2016

Primary Completion

March 1, 2021

Study Completion

March 1, 2021

Last Updated

December 28, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations